% Expired Patents = 25.0

Forward Citations = 8

Loading Chart...

7 inventors (with patents filed for the assignee):

Krishna Kalghatgi (2 out of 6 patents)

Seth N Birnbaum (2 out of 10 patents)

Edward A Wintner (2 out of 4 patents)

4. Gerald W Shipps (1 out of 9 patents)

5. Huw M Nash (1 out of 35 patents)

6. Satish Jindal (1 out of 7 patents)

7. Andrew N Tyler (1 out of 4 patents)

4 patents: Sort by Forward Citations

1. 6721665 - Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation (2004-04-13),

2. 6714875 - Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation (2004-03-30),

3. 6694267 - Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation (2004-02-17),

4. 6691046 - Method and apparatus for identifying unknown compounds in complex chemical mixtures using mass spectrometry and mass differential analysis (2004-02-10),

Company Overview

Neogenesis Drug Discovery, Inc. is a leading biopharmaceutical company specializing in the discovery and development of novel therapeutics for various diseases. With a focus on cutting-edge research and innovation, Neogenesis is dedicated to improving patient outcomes and advancing healthcare worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#411 in Cambridge, MA

#3,314 in Massachusetts

#60,671 in US

Cambridge, MA, United States of America

Neogenesis Drug Discovery, Inc.

Forward Citations = 8

7 inventors:

Krishna Kalghatgi (2 out of 6 patents)

Seth N Birnbaum (2 out of 10 patents)

Edward A Wintner (2 out of 4 patents)

4. Gerald W Shipps (1 out of 9 patents)

5. Huw M Nash (1 out of 35 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neogenesis Drug Discovery, Inc.. Retrieved from https://idiyas.com/company/neogenesis-drug-discovery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]